Stay updated on Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial
Sign up to get notified when there's something new on the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page.
Latest updates to the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page
- Check2 days agoChange DetectedRemoved the related topics section, including 'Ovarian cancer' and 'MedlinePlus Genetics', from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Locations section with new sites Region Sjælland and Haukeland; removed standalone Region Sjælland and Haukeland location subsections.SummaryDifference0.3%
- Check24 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the page. These changes improve discoverability and navigation without altering the study content or criteria.SummaryDifference0.1%
- Check45 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2, a minor version change with no visible impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check52 days agoChange DetectedThe page no longer displays a general operating-status notice for funding; trial details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check67 days agoChange DetectedNo significant content changes detected; the study page content remains focused on ENGOT-OV42 / NSGO-AVATAR trial details, eligibility criteria, and outcomes across screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page.